|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Product | |||||
| Net service and field option sales | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Product | |||||
| Net service and field option sales | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Research and development (R&D) costs | |||||
| Selling, general and administrative (SG&A) costs | |||||
| Other income | |||||
| Income from operations | |||||
| Interest and other, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Income after income taxes | |||||
| Profit from equity method investments | |||||
| Net income | |||||
| Basic net income per ordinary share (in EUR per share) | |||||
| Diluted net income per ordinary share (in EUR per share) | |||||
| Number of ordinary shares used in computing per share amounts: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...